Molecular targets in pituitary tumours.
Heaney
Anthony P
AP
Cedars-Sinai Research Institute, 8700 Beverly Blvd, Geffen School of Medicine at UCLA, Los Angeles, California 90048, USA. heaneya@cshs.org
Melmed
Shlomo
S
D000236:Adenoma / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D004338:Drug Combinations; D006801:Humans; D010902:Pituitary Gland / Q000187:drug effects* / Q000528:radiation effects; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D017481:Receptors, Somatostatin / Q000187:drug effects / Q000502:physiology; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000502:physiology; D013004:Somatostatin / Q000032:analysis / Q000494:pharmacology
D004338:Drug Combinations; D011954:Receptors, Dopamine; D017481:Receptors, Somatostatin; D011986:Receptors, Somatotropin; D013004:Somatostatin